ANI Pharmaceuticals Inc (ANIP)
Quick ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 144,861 | 221,121 | 48,228 | 100,300 | 7,864 |
| Short-term investments | US$ in thousands | 6,307 | — | — | — | — |
| Receivables | US$ in thousands | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 193,680 | 145,477 | 99,439 | 87,537 | 78,565 |
| Quick ratio | 0.78 | 1.52 | 0.49 | 1.15 | 0.10 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($144,861K
+ $6,307K
+ $—K)
÷ $193,680K
= 0.78
The quick ratio of ANI Pharmaceuticals Inc has shown significant fluctuations over the past five years.
- As of December 31, 2020, the quick ratio was very low at 0.10, indicating a potential liquidity issue as the company may have had difficulty meeting its short-term obligations with its most liquid assets.
- By December 31, 2021, the quick ratio improved substantially to 1.15, suggesting the company had a healthier liquidity position, with sufficient liquid assets to cover its current liabilities.
- However, there was a dip in the quick ratio by December 31, 2022, down to 0.49, raising concerns about the company's ability to meet short-term obligations with its readily available assets.
- The quick ratio then rebounded by December 31, 2023, reaching 1.52, indicating a strong liquidity position and the ability to quickly cover current liabilities.
- By December 31, 2024, the quick ratio decreased to 0.78, although it remained above 1, implying the company still had an adequate level of liquid assets to meet its short-term obligations.
Overall, ANI Pharmaceuticals Inc's quick ratio has shown volatility over the years, with periods of both strong and weak liquidity positions. Further analysis would be needed to understand the factors driving these fluctuations and their implications for the company's financial health.
Peer comparison
Dec 31, 2024